Ginkgo Bioworks Holdings Inc
NYSE:DNA

Watchlist Manager
Ginkgo Bioworks Holdings Inc Logo
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Watchlist
Price: 8.24 USD -0.24% Market Closed
Market Cap: 474.5m USD

Wall Street
Price Targets

DNA Price Targets Summary
Ginkgo Bioworks Holdings Inc

Wall Street analysts forecast DNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DNA is 10.88 USD with a low forecast of 9.09 USD and a high forecast of 14.7 USD.

Lowest
Price Target
9.09 USD
10% Upside
Average
Price Target
10.88 USD
32% Upside
Highest
Price Target
14.7 USD
78% Upside
Ginkgo Bioworks Holdings Inc Competitors:
Price Targets
4770
Allied Supreme Corp
59% Upside
357780
SoulBrain Co Ltd
17% Upside
4043
Tokuyama Corp
21% Upside
GIVN
Givaudan SA
28% Upside
2HRA
H&R GmbH & Co KgaA
10% Upside
VCT
Victrex PLC
25% Upside
CRDA
Croda International PLC
19% Upside
CLV
Clover Corporation Ltd
17% Upside

Revenue
Forecast

Revenue Estimate
Ginkgo Bioworks Holdings Inc

For the last 4 years the compound annual growth rate for Ginkgo Bioworks Holdings Inc's revenue is 31%. The projected CAGR for the next 3 years is 2%.

31%
Past Growth
2%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ginkgo Bioworks Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Ginkgo Bioworks Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DNA's stock price target?
Price Target
10.88 USD

According to Wall Street analysts, the average 1-year price target for DNA is 10.88 USD with a low forecast of 9.09 USD and a high forecast of 14.7 USD.

What is Ginkgo Bioworks Holdings Inc's Revenue forecast?
Projected CAGR
2%

For the last 4 years the compound annual growth rate for Ginkgo Bioworks Holdings Inc's revenue is 31%. The projected CAGR for the next 3 years is 2%.

Back to Top